Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997

British Journal of Haematology

Volumn 101, Issue 4, 1998, Pages 609-617

  Norfolk, D R ^a   Ancliffe, P J ^b   Contreras, M ^c   Hunt, B J ^d   Machin, S J ^b   Murphy, W G ^e   Williamson, L M ^f  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e Blood Transfusion Service Board   (Ireland)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Consensus conference; Platelet prophylaxis; Platelet therapy; Platelet transfusion; Thrombocytopenia

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; HEALTH CARE ORGANIZATION; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SAFETY; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; UNITED KINGDOM;

BACTERIAL INFECTIONS; BLOOD PLATELET DISORDERS; HUMANS; PLATELET TRANSFUSION; QUALITY CONTROL; RECURRENCE; RISK FACTORS; VIRUS DISEASES;

EID: 0031832998     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00773.x     Document Type: Conference Paper

References (47)

1. Alcorta, I., Pereira, A. & Ordinas, A. (1996) Clinical and laboratory factors associated with platelet transfusions refractoriness: a case-control study. British Journal of Haematology, 93, 220-224.
2. Anderson, N.A., Gray, S., Copplestone, J.A., Chan, D.C., Hamon, M., Prentice, A.G., Johnson, S.A., Phillips, M., van Waeg, G., Oakhill, A., Abeyasekera, S. & Pamphilon, D.H, (1996) A prospective randomised study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of non haemolytic febrile transfusion reactions. Transfusion Medicine, 6, 33-39.
3. Andrew, M., Castle, V. & Mitchell, L. (1989) Modified bleeding time in the infant. American Journal of Hematology, 30, 190-191.
4. Aye, M.T., Palmers, D.S., Giulivi, A. & Hashemi, S. (1995) Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion, 35, 117-124.
5. Babcock, R. B., Dumper, C. W. & Scharfman, W.B. (1976) Heparin induced thrombocytopenia. New England Journal of Medicine, 295, 237-239.
6. Bertolini, F. & Murphy, S. (1996) Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. A multi-center inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Transfusion, 36, 128-132.
7. Beutler, E. (1995) Platelet transfusions: the 20,000/μl trigger. Blood, 81, 1411-1413.
8. Blachman, M.A., Ali, A.M. & Richardson, H.L. (1994) Bacterial contamination of cellular blood components. Vox Sanguinis, 67, 25-34.
9. Blanchette, V.S., Kuhne, T., Hume, H. & Hellman, J. (1995) Platelet transfusion therapy in newborn infants. Transfusion Medicine Reviews, 9, 215-230.
10. Bolton-Maggs, P.H.B. & Moon, I. (1997) Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet, 350, 620-623.
11. Bordin, J.O., Heddle, N.M. & Blajchman, M.A. (1994) Biologic effects of leukocytes present in transfused cellular blood products. Blood, 84, 1703-1721.
12. British Committee for Standards in Haematology (1992) Guidelines for platelet transfusion. Transfusion Medicine, 2, 311-318.
13. Carr, J.M., Kruskall, M.S., Kaye, J.A. & Robinson, S.H. (1986) Efficacy of platelet transfusion in immune thrombocytopenia. American Journal of Medicine, 80, 1051-1054.
14. Erberst, M.E. & Berkowitz, L.R. (1994) Hemostasis in renal disease: pathophysiology and management. American Journal of Medicine, 96, 168-179.
15. Friedberg, R.C., Donnelly, F.F. & Mintz, P.D. (1994) Independent roles for platelet cross-matching and HLA in the selection of platelets for alloimmunized patients. Transfusion, 34, 215-220.
16. Gaydos, L.A., Freireich, E.J. & Mantel, N. (1962) The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. New England Journal of Medicine, 266, 905-909.
17. Gmur, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet, 338, 1223-1236.
18. Han, T., Stutzman, L., Cohen, E. & Kim, U. (1966) Effect of platelet transfusion on haemorrhage in patients with acute leukaemia. Cancer, 19, 1937-1942.
19. Harker, L.A. (1986) Bleeding after cardiopulmonary bypass. New England Journal of Medicine, 314, 1446-1447.
20. Heddle, N.M., Luba Klama, R.T., Singer, J., Richards, C., Fedak, P., Walker, I. & Kelton, J.G. (1994) The role of the plasma from platelet concentrates in transfusion reactions. New England Journal of Medicine, 331, 625-628.
21. Hersh, E.M., Bodey, G.P., Nies, B.A, & Freireich, E.J. (1965) Causes of death in acute leukemia: a ten year study of 414 patients from 1954-1963. Journal of the American Medical Association, 193, 99-103.
22. Kallis, P., Tooze, J.A., Talbot, S., Cowans, D., Bevan, D.H. & Treasure, T. (1994) Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Journal of Cardiothoracic Surgery, 8, 315-323.
23. Kelsey, H.C. (1992) An audit of the use of platelet concentrates in the prophylaxis of thrombocytopenic haemorrhage in a large haematology unit. Blood Coagulation and Fibrinolysis, 3, 647-649.
24. Levin, R.H, (1964) Handbook for Platelet Transfusion Therapy National Cancer Institute, Special Publication, Bethesda, Maryland.
25. Lin, L., Cook, D.N., Wiesehahn, G,P., Alfonso, R., Behrman, B., Cimino, G.D., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Fang, Y.M., Hanson, C.V., Hearst, J.E., Lin, C.Y., Londe, H.F., Metchette, K., Nerio, A.T., Pu, J.T., Reames, A.A., Rheinschmidt, M., Tessman, J., Isaacs, S.T., Wollowitz, S. & Corash, L. (1997) Photochemical inactivation of viruses and bacteria in platelet concentrates by the use of a novel psoralen and long-wavelength ultraviolet light. Transfusion, 37, 423-435.
26. Mallett, S.V. & Cox, D.J.A. (1992) Thromboclastography. British Journal of Anaesthesia, 69, 307-313.
27. Metcalfe, P., Williamson, L.M., Reutelingsperger, C.P.M., Swann, I., Ouwehand, W.H. & Goodall, A.H. (1997) Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometry study of different production methods. British Journal of Haematology, 98, 86-95.
28. Mueller-Eckhardt, C. (1986) Post-transfusion purpura. British Journal of Haematology, 64, 419-124.
29. Murphy, M.F., Metcalfe, P., Ord, J., Lister, T.A. & Waters, H.A. (1987) Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. British Journal of Haematology, 67, 255-260.
30. Murphy, M.F. & Waters, A.H. (1990) Platelet transfusions: the problem of refractoriness. Blood Reviews, 4, 16-24.
31. Murphy, M.F., Waters, A.H., Doughty, H.A., Hambley, H., Mibashan, R.S. (1994) Antenatal management of fetomaternal alloimmune thrombocytopenia: report of 15 affected pregnancies. Transfusion Medicine, 4, 281-292.
32. National Institutes of Health Consensus Conference: Platelet Transfusion Therapy (1987) Transfusion Medicine Reviews, 1, 195-200.
33. Norfolk, D.R. & Williamson, L.M. (1995) Leucodepletion of blood products by filtration. Blood Reviews, 9, 7-14.
34. Novotny, V.M.J., van Doorn, R., Witfleet, M.C., Class, F.H. & Brand, A. (1995) Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood, 85, 1736-1741.
35. Pamphilon, D.H., Potter, M., Cutts, M., Meenaghan, M., Rogers, W., Slade, R.R., Saimders, J., Tandy, N.P. & Fraser, I.D. (1990) Platelet concentrates irradiated with ultraviolet light retain satisfactory in vitro storage characteristics and in vivo survival. British Journal of Haematology, 75, 240-244.
36. Rebulla, P., Kinazzi, G., Marangoni, F., Avvisati, G., Gugliotta, L., Tognoni, G., Barbui, T., Mandelli, F. & Sirchia, G. (1997) A multicenter randomized study of the threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. New England Journal of Medicine, 337, 1870-1875.
37. Rinder, H.M., Murphy, M., Mitchell, J.G., Stocks, J., Ault, K.A. & Hillman, R.S. (1991) Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion, 31, 409-414.
38. Rogers, R.P. & Levin, I.A. (1990) A critical reappraisal of the bleeding time. Seminars in Thrombasis and Hemostasis, 16, 1-20.
39. Simon, T.L., Akl, B.F. & Murphy, W. (1984) Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Annals of Thoracic Surgery, 37, 359-364.
40. Slichter, S.J. & Marker, L.A. (1978) Thrombocytopenia: mechanisms and management of defects in platelet function. Clinical Haematology, 7, 523-529.
41. Sloand, E.M., Yu, M. & Klein, H.G. (1995) Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections. Transfusion, 36, 955-959.
42. Strauss, R.G. (1995) Clinical perspectives of platelet transfusion defining optimal dose. Journal of Clinical Apheresis, 10, 124-127.
43. Sweeney, J.D., Holme, S. & Stromberg R.R. (1995) In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion, 35, 125-130.
44. The Trial to Reduce Alloimmunizalion to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine, 337, 1861-1869.
45. Wagner, S.J., Friedman, L.I. & Dodd, R.Y. (1994) Transfusion-associated bacterial sepsis. Clinical Microbiology Reviews, 7, 290-302.
46. Wallace, E.L., Churchill, W H., Surgenor, D.M., Cho, G., McGurk, S. & Murphy, L. (1995) Collection and transfusion of blood and blood components in the United States (1992). Transfusion, 35, 802-812.
47. Williamson, L.M. & Warwick, R.M. (1995) Transfusion-associated graft versus host disease and its prevention. Blood Reviews, 9, 251-261.